Spot on mate, see a lot of spec punters getting annoyed when they buy in on hype and wonder why they don't make $$$. No understanding of the biotech process and time taken to go through the regulatory hurdles. NYR has a very promising suite of drug candidates, will gain some more interest and SP appreciation when they take to clinical trial. A lot more newsflow this yr that can re-rate the company.
NYR Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)